Hyperinflammation and Hyperferritinemia in Critically Ill Patients

Not yet recruitingOBSERVATIONAL

Enrollment

1,962

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

June 30, 2025

Study Completion Date

November 30, 2025

Conditions

Critical IllnessSepsisHyperferritinemiaHyperinflammatory Syndrome

Trial Locations (1)

Faculty of Medicine and Teaching Hospital, Charles University, Pilsen

All Listed Sponsors

lead

Charles University, Czech Republic

OTHER

NCT06820905 - Hyperinflammation and Hyperferritinemia in Critically Ill Patients | Biotech Hunter | Biotech Hunter